throbber
Trials@uspto.gov
`571-272-7822
`
`
`
`
`
`
`
`Paper 27
`Date: July 5, 2016
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`ARGENTUM PHARMACEUTICALS LLC,
`Petitioner,
`
`v.
`
`RESEARCH CORPORATION TECHNOLOGIES, INC.,
`Patent Owner.
`____________
`
`Case IPR2016-00204
`Patent RE38,551 E
`____________
`
`
`
`
`
`
`
`Before FRANCISCO C. PRATS and JACQUELINE WRIGHT BONILLA,
`Administrative Patent Judges.
`
`
`BONILLA, Administrative Patent Judge.
`
`
`
`ORDER
`Conduct of the Proceeding
`37 C.F.R. § 42.5
`
`
`
`

`

`IPR2016-00204
`Patent RE38,551 E
`
`
`On June 22, 2016, a conference call was conducted between
`respective counsel for the parties and Judges Prats and Bonilla. A court
`reporter also was present on the call.1 Both parties requested the call to
`address proposed motions for each party.
`Prior to the call, by e-mail correspondence sent to the Board on June
`13, 2016, Petitioner requested authorization to file: (1) a motion to
`consolidate this inter partes review (“IPR”) proceeding with a pending ex
`parte reexamination Control No. 90/013,709 requested by Petitioner
`concerning the same challenged patent at issue here; (2) under 37 C.F.R.
`§ 42.123(a), as supplemental information, pages of a trial transcript from a
`district court litigation concerning the challenged patent here; (3) a motion
`for discovery under 37 C.F.R. § 42.51(b) “relating to prior art relevant to the
`ground upon which trial was instituted”; and (4) as other supplemental
`information, “any relevant information obtained from discovery, if such
`discovery is permitted.”
`In the same e-mail correspondence, Patent Owner requested
`authorization to file: (1) an opposition to Petitioner’s Request for Rehearing
`(Paper 21) of our Decision to Institute (Paper 19) in this case; and (2) a
`motion to terminate ex parte reexamination Control No. 90/013,709
`mentioned above.
`During the call, in relation to the proposed motion to consolidate this
`IPR with the reexamination, the parties noted that Petitioner’s request for the
`
`
`1 Patent Owner, who arranged the court reporter, shall file a copy of a
`transcript of the call as an exhibit in due course. This Order summarizes
`statements made during the conference call. A more detailed record may be
`found in the transcript.
`
`
`
`2
`
`

`

`IPR2016-00204
`Patent RE38,551 E
`
`reexamination, filed on March 25, 2016, raised two grounds of rejection
`under the doctrine of obviousness-type double patenting (“OTDP”) based on
`U.S. Pat. No. 5,654,301 (“the ’301 patent”), not raised in a ground at issue
`here, in combination with other art raised in grounds in the Petition in this
`IPR. Specifically, Petitioner proposed two OTDP grounds of rejection based
`on the ’301 patent, in view of the ’729 patent2 and Kohn 19913 in the first
`ground, and in view of the ’729 patent and the LeGall thesis4 in the second
`ground.
`During the call, we pointed out that the Examiner granted the request
`for the ex parte reexamination on June 16, 2016, without issuing an Office
`Action in the case. In view of that status, we indicated to the parties that
`Petitioner’s request for a motion to consolidate may be premature at this
`time, but we would take the matter under advisement.
`After considering the matter further, we authorize Petitioner to file its
`requested motion to consolidate the two proceedings. As noted during the
`call, however, we are not inclined as an initial matter to consolidate matters
`here, not least of which because the reexamination at issue raises grounds
`based on OTDP, which cannot be the basis of a ground in an IPR, and ex
`parte reexamination differs procedurally from IPRs generally, particularly as
`
`
`2 Kohn et al., U.S. Patent No. 5,378,729, issued on Jan. 3, 1995 (“the ’729
`patent”) (Ex. 1009).
`3 Kohn et al., Preparation and Anticonvulsant Activity of a Series of
`Functionalized α-Heteroatom-Substituted Amino Acids, 34 J. MED. CHEM.
`2444–52 (1991) (“Kohn 1991”) (Ex. 1012).
`4 Philippe LeGall, 2-Substituted-2-acetamido-N-benzylacetamides.
`Synthesis, Spectroscopic and Anticonvulsant Properties (Dec. 1987) (“the
`LeGall thesis”) (Ex. 1008).
`
`
`
`3
`
`

`

`IPR2016-00204
`Patent RE38,551 E
`
`it relates to Petitioner’s involvement in the reexamination and the parties’
`ability to appeal to the Board a decision by the Examiner in the
`reexamination.
`That said, however, to give us an opportunity to fully address the
`merits of Petitioner’s position, we authorize Petitioner to brief the issue of
`consolidation further in a motion no longer than 10 pages, and authorize
`Patent Owner to respond in an opposition to that motion, in a paper no
`longer than 10 pages. We do not authorize a reply to the opposition.
`Petitioner also requested, as supplemental information under
`§ 42.123(a), certain pages of a trial transcript from a related district court
`litigation. Petitioner clarified during the call that those transcripts are the
`same transcripts it attempted to obtain as discovery in this case prior to
`institution, in an effort to establish that the Le Gall thesis qualified as prior
`art. Paper 13 (Petitioner’s Motion to Compel Discovery of Inconsistent
`Information and to File Exhibit 2025). We denied that Motion prior to
`institution (Paper 18), and determined in our Decision to Institute that
`Petitioner did not establish sufficiently in its Petition that the Le Gall thesis
`qualified as “printed publication” prior art. Paper 19, 8–12. In our Decision
`to Institute, we instituted a trial based on grounds that did not rely on the Le
`Gall thesis. Id. at 12–22, 23–24.
`In addition to the above request, Petitioner also indicated in the call
`that it requested other discovery and related supplemental information as it
`pertained to the public accessibility of the Le Gall thesis. Petitioner argued
`that it anticipated, in a Response yet to be filed, that Patent Owner would
`argue a reasonable expectation of success as relevant to non-obviousness
`based on information in the Le Gall thesis.
`
`
`
`4
`
`

`

`IPR2016-00204
`Patent RE38,551 E
`
`
`We indicated in the call that any request for discovery based on what
`Patent Owner might argue in a Response was premature. We denied
`Petitioner’s request for discovery, as well as any request to file supplemental
`information, as related to the public accessibility of Le Gall thesis.
`Patent Owner also requested authorization to file a 10-page opposition
`to Petitioner’s Request for Rehearing of our Decision to Institute, which
`Petitioner filed on June 6, 2016. Paper 21. During the call, we authorized
`Patent Owner to file the opposition within two weeks of the call, i.e., by July
`6, 2016. We do not authorize a reply to that opposition.
`Patent Owner further requested authorization to file a motion to
`terminate the ex parte reexamination, citing 35 U.S.C. § 315(d). We decline
`to grant that request at this time. We are not persuaded that the filing and
`granting of the ex parte reexamination request constitutes a type of
`harassment that justifies terminating a proceeding that will address grounds
`of rejection based on ODTP and different art, i.e., the ’301 patent, not at
`issue in the current IPR.
`
`Accordingly, it is:
`ORDERED that Petitioner is authorized to file, by Wednesday, July
`13, 2016, a 10-page motion to consolidate the current IPR with ex parte
`reexamination Control No. 90/013,709;
`FURTHER ORDERED that Patent Owner is authorized to file, by
`Wednesday, July 20, 2016, a 10-page opposition to Petitioner’s motion to
`consolidate the current IPR with the ex parte reexamination;
`FURTHER ORDERED that Patent Owner is authorized to file, by
`Wednesday, July 6, 2016, a 10-page opposition to Petitioner’s Request for
`
`
`
`5
`
`

`

`IPR2016-00204
`Patent RE38,551 E
`
`Rehearing (Paper 21);
`FURTHER ORDERED that Petitioner’s requests for authorization to
`file supplemental information under 37 C.F.R. § 42.123(a) and a motion for
`discovery are denied; and
`FURTHER ORDERED that Patent Owner’s request to file a motion to
`terminate ex parte reexamination Control No. 90/013,709 is denied.
`
`
`
`
`
`
`
`
`
`
`
`
`6
`
`

`

`IPR2016-00204
`Patent RE38,551 E
`
`PETITIONER:
` Matthew Dowd
`Justin Crotty
`ANDREWS KURTH LLP
`matthewdowd@andrewskurth.com
`justincrotty@andrewskurth.com
`
`PATENT OWNER:
`Andrea Reister
`Jennifer Robbins
`Enrique Longton
`COVINGTON & BURLING LLP
`areister@cov.com
`jrobbins@cov.com
`rlongton@cov.com
`
`
`
`7
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket